Evidence map›Paper›PMID 32996011›Full record

ArticleMolecular diversity2021

Identification of potential inhibitors of coronavirus hemagglutinin-esterase using molecular docking, molecular dynamics simulation and binding free energy calculation.

Chirag N Patel, Sivakumar Prasanth Kumar, Himanshu A Pandya, Rakesh M Rawal

Abstract read
In one paragraph

Article in Molecular diversity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Designing novel peptides with amyloid-Frontiers in artificial intelligence · 2025
    Article
  6. Article
  7. Article
  8. Frontiers in pharmacology · 2024
    Article
  9. Protective Effects of Rhamnetin in Carbapenem-ResistantInternational journal of molecular sciences · 2023
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Potential of Natural Alkaloids From Jadwar (Frontiers in molecular biosciences · 2022
    Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chirag N Patel *Department of Botany, Bioinformatics, and Climate Change Impacts Management, University School of Sciences, Gujarat University, Ahmedabad, 380009, India.ORCID http://orcid.org/0000-0003-0777-7720
Sivakumar Prasanth Kumar *Department of Life Sciences, University School of Sciences, Gujarat University, Ahmedabad, 380009, India.ORCID http://orcid.org/0000-0003-3461-2489
Himanshu A PandyaDepartment of Botany, Bioinformatics, and Climate Change Impacts Management, University School of Sciences, Gujarat University, Ahmedabad, 380009, India.ORCID http://orcid.org/0000-0003-4536-9541
Rakesh M RawalDepartment of Life Sciences, University School of Sciences, Gujarat University, Ahmedabad, 380009, India. rakeshrawal@gujaratuniversity.ac.in.ORCID http://orcid.org/0000-0002-7985-1187

Funding

Department of Science and Technology GSBTM/MD/JDR/1409/2017-18Gujarat Council on Science and Technology GUJCOST/Supercomputer/2019-20/1359
6 · The paper itself

Abstract

The pandemic outbreak of the Corona viral infection has become a critical global health issue. Biophysical and structural evidence shows that spike protein possesses a high binding affinity towards host angiotensin-converting enzyme 2 and viral hemagglutinin-acetylesterase (HE) glycoprotein receptor. We selected HE as a target in this study to identify potential inhibitors using a combination of various computational approaches such as molecular docking, ADMET analysis, dynamics simulations and binding free energy calculations. Virtual screening of NPACT compounds identified 3,4,5-Trihydroxy-1,8-bis[(2R,3R)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-2-yl]benzo[7]annulen-6-one, Silymarin, Withanolide D, Spirosolane and Oridonin as potential HE inhibitors with better binding energy. Furthermore, molecular dynamics simulations for 100 ns time scale revealed that most of the key HE contacts were retained throughout the simulations trajectories. Binding free energy calculations using MM/PBSA approach ranked the top-five potential NPACT compounds which can act as effective HE inhibitors.

Indexed as

COVID-19 Drug TreatmentAntiviral AgentsCOVID-19Hemagglutinins, ViralHumansMolecular Docking SimulationMolecular Dynamics SimulationPandemicsProtein BindingSARS-CoV-2Viral Fusion ProteinsAntiviral Agentshemagglutinin esteraseHemagglutinins, ViralViral Fusion ProteinsAngiotensin-converting enzyme 2 (ACE2)COVID-19 virusHemagglutinin-acetylesterase (HE) glycoproteinMolecular dockingMolecular dynamics simulationsNPACT compounds

Identifiers

PMID32996011
PMCPMC7524381

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.